A COMPARISON OF DIFFERENT FORMULATIONS AND DOSAGE ADMINISTRATIONS OF GEMFIBROZIL

被引:10
作者
KOVANEN, PT
KOSKINEN, P
MANNINEN, V
机构
关键词
D O I
10.1016/0002-9149(86)90663-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:G31 / G34
页数:4
相关论文
共 13 条
[1]  
[Anonymous], 1984, JAMA, V251, P365
[2]  
DAHLEN G, 1980, ARTERY, V7, P224
[3]   GEMFIBROZIL AND CLOFIBRATE IN TREATMENT OF HYPERLIPEMIAS - COMPARATIVE TRIAL [J].
EISALO, A ;
MANNINEN, V .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1976, 69 :44-46
[4]   SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].
KANNEL, WB ;
CASTELLI, WP ;
GORDON, T ;
MCNAMARA, PM .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :1-+
[5]  
KAUKOLA S, 1981, ACTA MED SCAND, V209, P69
[6]   CLINICAL-RESULTS WITH GEMFIBROZIL AND BACKGROUND TO THE HELSINKI HEART-STUDY [J].
MANNINEN, V .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (04) :B35-B38
[7]  
Manninen V, 1982, Acta Med Scand Suppl, V668, P82
[8]  
MANNINEN V, 1982, RES CLIN FORUMS, V4, P9
[9]  
MILLER GJ, 1975, LANCET, V1, P16
[10]  
NYE ER, 1980, NEW ZEAL MED J, V92, P345